Cargando…
Annotation matters: validating the discovery of cancer drivers
Advanced sequencing techniques have helped unveil numerous new, potential cancer driver mutations. However, manual curation and analysis of gene and protein annotation are essential to verify such discoveries. Our recent study of STK19 (Serine Threonine Kinase 19), a previously identified melanoma d...
Autores principales: | Rodríguez-Martínez, Marta, Svejstrup, Jesper Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671066/ https://www.ncbi.nlm.nih.gov/pubmed/33235910 http://dx.doi.org/10.1080/23723556.2020.1806679 |
Ejemplares similares
-
Discovery and validation of the antimetastatic activity of citalopram in colorectal cancer
por: Iskar, Murat, et al.
Publicado: (2015) -
A scientific journey from discovery to validation of efficacy in cancer patients: HAMLET and alpha1-oleate
por: Ho, James C.S., et al.
Publicado: (2021) -
Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses
por: Goc, Jérémy, et al.
Publicado: (2014) -
Cancer neoantigens and immunogenicity: mutation position matters
por: Capietto, Aude-Hélène, et al.
Publicado: (2020) -
Acute myeloid leukemia therapeutics: CARs in the driver’s seat
por: Mardiros, Armen, et al.
Publicado: (2013)